BioCentury | Sep 7, 2018
Company News

Pfizer, Cytoo to develop DMD muscle-on-a-plate platform

...Pfizer Inc. (NYSE:PFE) partnered with Cytoo S.A. (Grenoble, France) to modify Cytoo’s MyoScreen platform in order to...
...of DMD Candidate" ). Cytoo S.A., Grenoble, France Pfizer Inc. (NYSE:PFE), New York, N.Y. Business: Musculoskeletal Alicia Parker Cytoo S.A. Pfizer...
BioCentury | Dec 19, 2011
Company News

Cenix, Cytoo, Center for Physical Sciences and Technology, Ecole polytechnique federale de Lausanne, University of Heidelberg high throughput screening news

...received a three-year €4 million ($5.3 million) grant under the EU's seventh Framework Program (FP7). Cytoo...
...Cenix offers RNAi screening services. Details were not disclosed. Cenix BioScience GmbH , Dresden, Germany Cytoo S.A....
BioCentury | Dec 5, 2011
Financial News

Cytoo completes venture financing

Cytoo S.A. , Grenoble, France Business: Microarrays, Supply/Service Date completed: 11/21/11 Type: Venture financing Raised: $10 million Investors: Sham; Entrepreneurs Fund; Auriga Partners; and an individual investor WIR Staff...
BioCentury | Oct 3, 2011
Company News

Cellectis, Cytoo supply/service, cancer news

...Cellectis and Cytoo partnered with the French Alternative Energies and Atomic Energy Commission (CEA) to develop...
...which is called ETICS, will develop the kits to be commercialized worldwide by both companies. Cytoo...
...kits will combine Cellectis' genetically modified cells that express physiological levels of fluorescent markers with Cytoo's...
BioCentury | Nov 23, 2009
Company News

Cytoo management update

...Grenoble, France Business: Microarrays, Supply/Service Hired: William Sharp as president and CEO for Cytoo's Cytoo...
BioCentury | Oct 5, 2009
Financial News

Cytoo completes venture financing

Cytoo S.A. , Grenoble, France Business: Microarrays, Supply/Service Date completed: 9/28/09 Type: Venture financing Raised: $4.7 million Investors: Auriga Partners; individual investors WIR Staff...
Items per page:
1 - 6 of 6
BioCentury | Sep 7, 2018
Company News

Pfizer, Cytoo to develop DMD muscle-on-a-plate platform

...Pfizer Inc. (NYSE:PFE) partnered with Cytoo S.A. (Grenoble, France) to modify Cytoo’s MyoScreen platform in order to...
...of DMD Candidate" ). Cytoo S.A., Grenoble, France Pfizer Inc. (NYSE:PFE), New York, N.Y. Business: Musculoskeletal Alicia Parker Cytoo S.A. Pfizer...
BioCentury | Dec 19, 2011
Company News

Cenix, Cytoo, Center for Physical Sciences and Technology, Ecole polytechnique federale de Lausanne, University of Heidelberg high throughput screening news

...received a three-year €4 million ($5.3 million) grant under the EU's seventh Framework Program (FP7). Cytoo...
...Cenix offers RNAi screening services. Details were not disclosed. Cenix BioScience GmbH , Dresden, Germany Cytoo S.A....
BioCentury | Dec 5, 2011
Financial News

Cytoo completes venture financing

Cytoo S.A. , Grenoble, France Business: Microarrays, Supply/Service Date completed: 11/21/11 Type: Venture financing Raised: $10 million Investors: Sham; Entrepreneurs Fund; Auriga Partners; and an individual investor WIR Staff...
BioCentury | Oct 3, 2011
Company News

Cellectis, Cytoo supply/service, cancer news

...Cellectis and Cytoo partnered with the French Alternative Energies and Atomic Energy Commission (CEA) to develop...
...which is called ETICS, will develop the kits to be commercialized worldwide by both companies. Cytoo...
...kits will combine Cellectis' genetically modified cells that express physiological levels of fluorescent markers with Cytoo's...
BioCentury | Nov 23, 2009
Company News

Cytoo management update

...Grenoble, France Business: Microarrays, Supply/Service Hired: William Sharp as president and CEO for Cytoo's Cytoo...
BioCentury | Oct 5, 2009
Financial News

Cytoo completes venture financing

Cytoo S.A. , Grenoble, France Business: Microarrays, Supply/Service Date completed: 9/28/09 Type: Venture financing Raised: $4.7 million Investors: Auriga Partners; individual investors WIR Staff...
Items per page:
1 - 6 of 6